W
Wilson S. Colucci
Researcher at Boston University
Publications - 345
Citations - 50057
Wilson S. Colucci is an academic researcher from Boston University. The author has contributed to research in topics: Heart failure & Inotrope. The author has an hindex of 106, co-authored 344 publications receiving 48016 citations. Previous affiliations of Wilson S. Colucci include University of Medicine and Dentistry of New Jersey & Cardiovascular Institute of the South.
Papers
More filters
Journal ArticleDOI
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Milton Packer,Michael R. Bristow,Jay N. Cohn,Wilson S. Colucci,Michael B. Fowler,Edward M. Gilbert,Neil H. Shusterman +6 more
TL;DR: Carvedilol reduces the risk or death as well as the risk of hospitalization for cardiovascular causes in patients with heart failure who are receiving treatment with digoxin, diuretics, and an angiotensin-converting-enzyme inhibitor.
Journal Article
The Effect of Carvedilol on Morbidity and Mortality in Patients With Chronic Heart Failure
Milton Packer,Michael R. Bristow,Jay N. Cohn,Wilson S. Colucci,Michael B. Fowler,Edward M. Gilbert,Neil H. Shusterman +6 more
TL;DR: In this paper, a double-blind, placebo-controlled, stratified program, in which patients were assigned to one of four treatment protocols on the basis of their exercise capacity, was presented.
Journal ArticleDOI
Targeted Anticytokine Therapy in Patients with Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)
Douglas L. Mann,John J.V. McMurray,Milton Packer,Karl Swedberg,Jeffrey S. Borer,Wilson S. Colucci,Jacques Djian,Helmut Drexler,Arthur M. Feldman,Lars Køber,Henry Krum,Peter Liu,Markku S. Nieminen,Luigi Tavazzi,Dirk J. van Veldhuisen,Anders Waldenström,Marshelle Warren,Arne Westheim,Faiez Zannad,Thomas Fleming +19 more
TL;DR: The results of RENEWAL rule out a clinically relevant benefit of etanercept on the rate of death or hospitalization due to chronic heart failure.
Journal ArticleDOI
Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.
Michael S. Cuffe,Robert M. Califf,Kirkwood F. Adams,Raymond L. Benza,Robert C. Bourge,Wilson S. Colucci,Barry M. Massie,Christopher M. O'Connor,Ileana L. Piña,Rebecca Quigg,Marc A. Silver,Mihai Gheorghiade +11 more
TL;DR: In this article, the authors evaluated the effect of intravenous milrinone on intermediate-term clinical outcomes of patients with chronic heart failure in a randomized, double-blind, placebo-controlled trial.